Media Centre
News

We represented Sun Pharma in the acquisition of the minority interest in Taro

Nir Dash Natan Wiesenberg Niv Sivan David Azimov

23 January 2024

It was our pleasure to represent Sun Pharmaceutical Industries Limited (SUN.NS), in its acquisition of the minority interest in Taro Pharmaceutical Industries (TARO.N). The transaction represents a valuation of Taro of approximately $ 1.65 billion, and the total amount of the transaction is expected to be approximately $ 350 million.
This transaction was led by partners Nir Dash, Niv Sivan, and Nathan Wiesenberg and associate David Azimov, as well as specialist from different teams in the firm.

Have a question on this topic? We are here to help

Every case is unique. Let's talk about yours.

Contact Us Now

More News, Insights & Events

Approved: A New Framework for “Alternative” Mutual Funds Draft Bill for the Supervision of Financial Services (Issuance of Stablecoins) – Published for Public Comments Meet our new Partners – 2026
JOIN OUR
Newsletter

    © 2020, All rights reserved, Herzog Law
    Site by Gootte

    The information contained in this web site is provided for informational purposes only and should not be construed as legal advice on any subject matter and should not be relied upon as such. Herzog accepts no responsibility for any consequences whatsoever arising from use of the information contained in this web site. The accessing of information contained in this web site shall under no circumstances be considered as creating an attorney-client relationship between Herzog and any party accessing this web site. Contacting through email any lawyer named in this web site or sending information without prior agreement of Herzog shall not be construed as automatically creating an attorney-client relationship between Herzog and the party sending an email or information. The material contained in this web site has been created by and remains the property of Herzog. No reproduction, transmission, publication or any other form of dissemination shall be permitted unless the prior written consent of Herzog has been obtained. This web site may contain links to other web sites operated by third parties. Herzog does not sponsor, approve or endorse the content of any such web site and is not responsible for the materials appearing in such sites.